Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Colorectal Neoplasms 4588Pancreatic Neoplasms 2837Carcinoma, Hepatocellular 2473Stomach Neoplasms 2325Colonic Neoplasms 1790Rectal Neoplasms 1714Esophageal Neoplasms 1373Liver Neoplasms 920Neoplasms 913Breast Neoplasms 836Neoplasm Metastasis 761Carcinoma, Non-Small-Cell Lung 702Cholangiocarcinoma 581Lung Neoplasms 555Ovarian Neoplasms 533Esophageal Squamous Cell Carcinoma 510Gastrointestinal Neoplasms 494Melanoma 381Prostatic Neoplasms 371Biliary Tract Neoplasms 370Head and Neck Neoplasms 303Uterine Cervical Neoplasms 286Carcinoma, Renal Cell 282Adenocarcinoma Of Esophagus 273Sarcoma 263Squamous Cell Carcinoma of Head and Neck 262Gastrointestinal Stromal Tumors 251Endometrial Neoplasms 233Urinary Bladder Neoplasms 226Gallbladder Neoplasms 223

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoadjuvant Chemotherapy × Gastrointestinal × Clear all
NCT06459921 2024-10-10

Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer

Xijing Hospital

Phase 2 Not yet recruiting
200 enrolled
Gastrointestinal

Neoadjuvant Chemotherapy

NCT06172036 2023-12-15

CAPT-02

Zhejiang University

Phase 2 Not yet recruiting
180 enrolled
Gastrointestinal

Neoadjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡